Investors considering purchasing shares of 10x Genomics Inc (TXG) may benefit from selling puts as an alternative strategy. One interesting put contract is the February 2026 put at the $10 strike, with a bid of 95 cents, offering a 20.3% annualized rate of return. Selling a put does not provide access to the stock’s upside potential unless the contract is exercised. The stock’s historical volatility and fundamental analysis can help assess if selling the put at the $10 strike is a good risk-reward opportunity. Put volume among S&P 500 components is above normal, indicating more put buyers than expected in options trading.

Read more at Nasdaq: Commit To Buy 10x Genomics At $10, Earn 20.3% Annualized Using Options